AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, F.
Right arrow Articles by Miyazaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, F.
Right arrow Articles by Miyazaki, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Partial Splenic Embolization for the Treatment of Hereditary Spherocytosis

Fumio Kimura1, Hiroshi Ito, Hiroaki Shimizu, Akira Togawa, Masayuki Otsuka, Hiroyuki Yoshidome, Fumihiko Shimamura, Atsushi Kato, Yuji Nukui, Satoshi Ambiru and Masaru Miyazaki

1 All authors: Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670 Japan.



View larger version (111K):

[in a new window]
 
Fig. 1. 33-year-old woman with hereditary spherocytosis who responded to partial splenic embolization. CT scan (window level, 30 H; width, 250 H) 5 days after embolization shows spleen 96% infarcted and line of demarcation between infarcted (arrows) and normal regions.

 


View larger version (16K):

[in a new window]
 
Fig. 2A. Changes in blood values after partial splenic embolization. Black square, black triangle, circle, white triangle, and white square correspond to patient numbers 1, 2, 3, 4, and 5, respectively. Graph shows changes in hemoglobin levels. In all patients, hemoglobin levels were maintained at 12 g/dL or more during follow-up periods.

 


View larger version (17K):

[in a new window]
 
Fig. 2B. Changes in blood values after partial splenic embolization. Black square, black triangle, circle, white triangle, and white square correspond to patient numbers 1, 2, 3, 4, and 5, respectively. Graph shows changes in hematocrit values. In all patients, hematocrit values were maintained at 33% or more during follow-up periods.

 


View larger version (18K):

[in a new window]
 
Fig. 2C. Changes in blood values after partial splenic embolization. Black square, black triangle, circle, white triangle, and white square correspond to patient numbers 1, 2, 3, 4, and 5, respectively. Graph shows changes in reticulocyte counts. In four of five patients, reticulocyte counts were maintained at less than 55 x 109/L during follow-up periods. In another patient, reticulocyte count partially relapsed at 12 months after embolization and stabilized at approximately 100 x 109/L for 7 years.

 


View larger version (17K):

[in a new window]
 
Fig. 2D. Changes in blood values after partial splenic embolization. Black square, black triangle, circle, white triangle, and white square correspond to patient numbers 1, 2, 3, 4, and 5, respectively. Graph shows changes in total serum bilirubin levels. Levels were maintained at less than 60 µmol/L during follow-up periods in all patients.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.